New pain block could cut opioid use after lung surgery

NCT ID NCT07441902

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a long-lasting numbing drug (liposomal bupivacaine) combined with a standard numbing drug can improve pain control after lung surgery. About 134 adults having keyhole lung surgery will receive either the combination or standard care. The goal is to see if this approach reduces the need for rescue painkillers and improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liposomal bupivacaine (a long-lasting numbing medicine) combined with regular bupivacaine
What this could lead to
If it works, this could provide a better way to manage pain after lung surgery, reducing the need for strong opioid painkillers and lowering the risk of chronic pain.
What could go wrong
This is a relatively small, early-stage trial. The long-acting numbing drug may not prove significantly better than standard care, and there is always a risk of side effects like nerve damage or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPOSOMAL BUPIVACAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tiantan Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100070, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.